Search research articles
Contact Us
Filters
Showing results (141-150 of 250) with videos related to
Page
of 25
Sort By:
Cancer Research and Treatment
|
June 20, 2024
Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal Adenocarcinoma
Yoo Na Lee, Min Kyu Sung, Dae Wook Hwang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 6, 2021
Implication of CD69<sup>+</sup> CD103<sup>+</sup> tissue-resident-like CD8<sup>+</sup> T cells as a potential immunotherapeutic target for cholangiocarcinoma
Hyung-Don Kim, Seongju Jeong, Seongyeol Park, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 6, 2021
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma
Eo Jin Kim, Changhoon Yoo, Hyo Jeong Kang, et al.
Cancers
|
February 15, 2022
A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY
Jwa Hoon Kim, Changhoon Yoo, Seyoung Seo, et al.
Cancer Research and Treatment
|
October 22, 2024
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials
Jaewon Hyung, Minsu Kang, Ilhwan Kim, et al.
European Radiology
|
August 27, 2020
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy
Jong Keon Jang, Jae Ho Byun, Ji Hun Kang, et al.
Journal of Clinical Medicine
|
May 20, 2020
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer
Woohyung Lee, Yejong Park, Jae Woo Kwon, et al.
JAMA Network Open
|
October 1, 2025
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical Trial
Hyehyun Jeong, Changhoon Yoo, Ilhwan Kim, et al.
Oncotarget
|
October 21, 2016
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
Seyoung Seo, Jung Yong Hong, Shinkyo Yoon, et al.
Annals of Surgical Oncology
|
May 7, 2026
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 Trial
Changhoon Yoo, Hyehyun Jeong, Inkeun Park, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 250) with videos related to
Sort By:
Page
of 25
Cancer Research and Treatment
|
June 20, 2024
Clinical Outcomes of Surgery after Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Ductal Adenocarcinoma
Yoo Na Lee, Min Kyu Sung, Dae Wook Hwang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 6, 2021
Implication of CD69<sup>+</sup> CD103<sup>+</sup> tissue-resident-like CD8<sup>+</sup> T cells as a potential immunotherapeutic target for cholangiocarcinoma
Hyung-Don Kim, Seongju Jeong, Seongyeol Park, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 6, 2021
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma
Eo Jin Kim, Changhoon Yoo, Hyo Jeong Kang, et al.
Cancers
|
February 15, 2022
A Phase II Study to Compare the Safety and Efficacy of Direct Oral Anticoagulants versus Subcutaneous Dalteparin for Cancer-Associated Venous Thromboembolism in Patients with Advanced Upper Gastrointestinal, Hepatobiliary and Pancreatic Cancer: PRIORITY
Jwa Hoon Kim, Changhoon Yoo, Seyoung Seo, et al.
Cancer Research and Treatment
|
October 22, 2024
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized Trials
Jaewon Hyung, Minsu Kang, Ilhwan Kim, et al.
European Radiology
|
August 27, 2020
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy
Jong Keon Jang, Jae Ho Byun, Ji Hun Kang, et al.
Journal of Clinical Medicine
|
May 20, 2020
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer
Woohyung Lee, Yejong Park, Jae Woo Kwon, et al.
JAMA Network Open
|
October 1, 2025
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical Trial
Hyehyun Jeong, Changhoon Yoo, Ilhwan Kim, et al.
Oncotarget
|
October 21, 2016
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
Seyoung Seo, Jung Yong Hong, Shinkyo Yoon, et al.
Annals of Surgical Oncology
|
May 7, 2026
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 Trial
Changhoon Yoo, Hyehyun Jeong, Inkeun Park, et al.
Page
of 25